Genomic Health, Inc. To Announce Second Quarter 2006 Financial Results And Host Conference Call On Tuesday, August 1, 2006

REDWOOD CITY, Calif., July 25 /PRNewswire-FirstCall/ -- Genomic Health, Inc. today announced that the company will host a conference call and webcast on Tuesday, August 1, 2006 at 4:30 p.m. Eastern Time to discuss its second quarter financial results. The call and webcast will follow the release of the second quarter financial results after market close.

To access the live conference call via phone, please dial 877-356-8064 from the United States and Canada or 706-758-4314 internationally. The conference ID is 3456542. Please dial in approximately ten minutes prior to the start of the call. A telephone replay will be available beginning approximately one hour after the call through August 8 and may be accessed by dialing 800-642-1687 from the United States and Canada or 706-645-9291 internationally. The replay passcode is 3456542.

Additionally, you may access the live and subsequently archived webcast of the conference call from the Investor Relations section of the Company’s web site at http://investor.genomichealth.com . Please connect to the web site at least 15 minutes prior to the call to allow for any software download that may be necessary. An archived replay of the call will be available until the next quarterly call.

About Genomic Health

Genomic Health, Inc. is a life science company focused on the development and commercialization of genomic-based clinical laboratory services for cancer that allow physicians and patients to make individualized treatment decisions. In 2004, Genomic Health launched its first test service, Oncotype DX(TM), which has been shown to predict the likelihood of breast cancer recurrence and chemotherapy benefit in early-stage breast cancer patients. The company was founded in 2000 and is located in Redwood City, California. For more information, please visit www.genomichealth.com.

Genomic Health, Inc.

CONTACT: Brad Cole of Genomic Health, Inc., +1-650-569-2281, orinvestors@genomichealth.com; or media, Emily Faucette of WeissCommPartners, +1-415-946-1066, or media@genomichealth.com

MORE ON THIS TOPIC